9780849350832-0849350832-Innovative Leukemia and Lymphoma Therapy (Basic and Clinical Oncology)

Innovative Leukemia and Lymphoma Therapy (Basic and Clinical Oncology)

ISBN-13: 9780849350832
ISBN-10: 0849350832
Edition: 1
Author: Bertrand Coiffier, Gertjian J. L. Kaspers, Michael C. Heinrich, Elihu H. Estey
Publication date: 2008
Publisher: CRC Press
Format: Hardcover 616 pages
FREE US shipping
Buy

From $99.00

Book details

ISBN-13: 9780849350832
ISBN-10: 0849350832
Edition: 1
Author: Bertrand Coiffier, Gertjian J. L. Kaspers, Michael C. Heinrich, Elihu H. Estey
Publication date: 2008
Publisher: CRC Press
Format: Hardcover 616 pages

Summary

Innovative Leukemia and Lymphoma Therapy (Basic and Clinical Oncology) (ISBN-13: 9780849350832 and ISBN-10: 0849350832), written by authors Bertrand Coiffier, Gertjian J. L. Kaspers, Michael C. Heinrich, Elihu H. Estey, was published by CRC Press in 2008. With an overall rating of 3.5 stars, it's a notable title among other Cancer (Diseases & Physical Ailments) books. You can easily purchase or rent Innovative Leukemia and Lymphoma Therapy (Basic and Clinical Oncology) (Hardcover) from BooksRun, along with many other new and used Cancer books and textbooks. And, if you're looking to sell your copy, our current buyback offer is $0.3.

Description

Innovative Leukemia and Lymphoma Therapy provides a complete and up-to-date overview of the exciting new treatment modalities in leukemia and lymphoma that are being introduced in the clinic today. Written by international experts in the field, this volume examines clinical studies on topics such as:

  • tyrosine kinase inhibitors, histon deacetylase inhibitors, and farnesyl transferase inhibitors
  • radioimmunotherapy, gene-directed therapy, and immunotherapy by vaccination
  • monoclonal antibodies
  • anti-angiogenesis approaches

Within each chapter, this well-illustrated, comprehensive source provides a summary of the rationale for treatment, the pathways that are involved, and the translational research to students, scientists, and clinicians. In addition, this book focuses on the concerns of conventional but novel anticancer agents, modulation of classical multidrug resistance, and modulators of single agent drug resistance.

Rate this book Rate this book

We would LOVE it if you could help us and other readers by reviewing the book